GPCR
Structure Therapeutics Inc.Company with tickers: GPCR
CIK
1888886
CUSIP
86366E106
Shares Outstanding
71,074,516
13F Activity (30d)
176 filings
176 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $89,379,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $66,507,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-89,379,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-75,968,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.35 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.35 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |